Finerenone Approved as First-in-Class Treatment for Chronic Kidney Disease Associated with Type 2 DiabetesJuly 12th 2021
The first nonsteroidal mineralocorticoid receptor antagonist to be approved for adults with T2D-associated CKD fills a significant treatment void for millions of patients.
Clinical Trial Updates at the ADA Scientific Sessions 2021: A few primary care mustsJune 21st 2021
The American Diabetes Association 2021 Scientific Sessions run from June 25 to 29. This short slide show highlights 6 clinical trial updates that are a "must see" for primary care clinicians.